- ISIN DE0006599905
- Country Deutschland
Latest Reports
News Functions
Additional Functions
18 November 2024
Merck KGaA
Q3 statement / Q3 financial report 2024
8 August 2024
Merck KGaA
Half-yearly financial report 2024
15 May 2024
Merck KGaA
Q1 statement / Q1 financial report 2024
30 April 2024
Merck KGaA
Annual financial report 2023
22 November 2023
Merck KGaA
Q3 statement / Q3 financial report 2023
19 September 2023
Merck KGaA
Half-yearly financial report 2023
11 May 2023
Merck KGaA
Q1 statement / Q1 financial report 2023
3 March 2023
Merck KGaA
Annual financial report 2022
18 November 2022
Merck KGaA
Q3 statement / Q3 financial report 2022
5 August 2022
Merck KGaA
Half-yearly financial report 2022
12 May 2022
Merck KGaA
Q1 statement / Q1 financial report 2022
7 March 2022
Merck KGaA
Annual financial report 2021
Merck KGaA
Jahresfinanzbericht 2021
11 November 2021
Merck KGaA
Q3 statement / Q3 financial report 2021
6 August 2021
Merck KGaA
Half-yearly financial report 2021
12 May 2021
Merck KGaA
Q1 statement / Q1 financial report 2021
Latest News
News Functions
Additional Functions
4 October 2024
Merck KGaA
26 July 2024
Merck KGaA
Merck KGaA: Strong 2nd Quarter, Guidance raised
24 June 2024
Merck KGaA
Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
23 May 2024
Merck KGaA
21 May 2024
Merck KGaA
16 May 2024
Merck KGaA